More Definitive Evidence Carves Out LVEF Zone for Beta-Blockers After MI

(MedPage Today) — MADRID — Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.
Putting aside their known…